<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02105831</url>
  </required_header>
  <id_info>
    <org_study_id>CEU in LVAD</org_study_id>
    <nct_id>NCT02105831</nct_id>
  </id_info>
  <brief_title>Skeletal Muscle Perfusion With LVAD</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Advanced heart failure (when the heart pump fails) is associated with symptoms such as&#xD;
      shortness of breath and extreme fatigue. Some of these symptoms are simply due to failure of&#xD;
      the pump, however abnormal regulation of blood flow to the muscles of the body is also a&#xD;
      potential mechanism. Left ventricular assist devices are mechanical pumps used to compensate&#xD;
      for patients with failing hearts either as a bridge to heart transplant or as long term&#xD;
      therapy. Whether or not these pumps improve muscle flow and whether this is a determinant in&#xD;
      the improvement of symptoms is unknown. Understanding how skeletal muscle and heart perfusion&#xD;
      is altered in heart failure patients before and after implantation of an LVAD could provide&#xD;
      further insight into the beneficial effects of this therapy.&#xD;
&#xD;
      Specific Aims:&#xD;
&#xD;
        1. To evaluate skeletal muscle and heart perfusion studies before and after LVAD&#xD;
           implantation&#xD;
&#xD;
        2. To compare functional status with degree of skeletal muscle perfusion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods:&#xD;
&#xD;
      Thirty patients deemed to be candidates for LVAD from either outpatient heart failure clinic&#xD;
      or inpatient cardiology service will be studies. Skeletal muscle perfusion imaging using&#xD;
      standard of care ultrasound technology will be performed prior to LVAD implant and then 3&#xD;
      months post implant. Functional status by six minute walk test and specialized stress test&#xD;
      will be assessed at 3 months post implant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">February 1, 2014</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Skeletal muscle perfusion on contrast enhanced ultrasound</measure>
    <time_frame>3 months</time_frame>
    <description>Skeletal muscle perfusion will be quantified:&#xD;
Prior to LVAD placement&#xD;
3 months post LVAD placement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>6 minute walk test</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>CEU skeletal muscle perfusion imaging</arm_group_label>
    <description>Heart failure with LVAD Contrast ultrasound skeletal muscle perfusion imaging</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Contrast ultrasound skeletal muscle perfusion imaging</intervention_name>
    <description>1. Contrast ultrasound perfusion imaging will be performed in patients in whom LVAD will be placed for clinical indications of severe heart failure.</description>
    <arm_group_label>CEU skeletal muscle perfusion imaging</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        1. Heart failure patients being referred for LVAD&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients deemed to be candidates for a LVAD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  severe peripheral artery disease&#xD;
&#xD;
          -  skeletal muscle disorder&#xD;
&#xD;
          -  severe congenital heart disease&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  patients &lt;18 yo&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jonathan R Lindner, MD</last_name>
    <phone>503 494-8750</phone>
    <email>lindnerj@ohsu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan R Lindner, MD</last_name>
      <phone>503-494-8750</phone>
      <email>lindnerj@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Jonathan R Lindner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>April 2, 2014</study_first_submitted>
  <study_first_submitted_qc>April 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2014</study_first_posted>
  <last_update_submitted>August 21, 2018</last_update_submitted>
  <last_update_submitted_qc>August 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Jonathan R. Lindner, MD</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>left ventricular assist device</keyword>
  <keyword>contrast ultrasound</keyword>
  <keyword>perfusion imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

